Cellectis Underwhelms, What’s The Next Data Point?
Research - Cellectis’ (CLLS)(ALCLS) presentations at ASH were, in our view, underwhelming. We discussed last week a high-risk trade over the weekend as initial human results with UCART19 … Continue Reading
Premium